Provided by Tiger Trade Technology Pte. Ltd.

Anavex Life Sciences

2.66
-0.0900-3.27%
Pre-market: 2.700.0400+1.50%04:42 EDT
Volume:433.77K
Turnover:1.15M
Market Cap:246.51M
PE:-18.40
High:2.74
Open:2.71
Low:2.62
Close:2.75
52wk High:10.38
52wk Low:2.26
Shares:92.67M
Float Shares:87.17M
Volume Ratio:0.94
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1446
EPS(LYR):-0.5438
ROE:-12.80%
ROA:-9.70%
PB:2.19
PE(LYR):-4.89

Loading ...

Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders

THOMSON REUTERS
·
Aug 11

Anavex Faces PVG Activist Slate Seeking Board Seats at Sept. 24 Shareholder Meeting

Reuters
·
Aug 11

Anavex Life Sciences Delays Quarterly SEC Filing

TIPRANKS
·
Aug 11

Anavex Life Sciences Delays Filing Quarterly Report for June 30, 2026 Quarter

Reuters
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Anavex Life Sciences Corp Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 07

Anavex Life Sciences Aims to Refresh Board with Two New Candidates

Dow Jones
·
Aug 03

Anavex Urges Investors to Reject PVG Proxy Bid to Replace Entire Board at 2026 Annual Meeting

Reuters
·
Aug 03

Anavex Life Sciences Announces Plans to Refresh Board to Continue Overseeing Critical Progress and Stockholder Value Creation

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Nominates Gautam Patel and Adrian Senderowicz as Independent Directors

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Urges Stockholders to Reject Pvg Asset Management and Patrick S. Adams Control Attempt

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Files Preliminary Proxy Statement with SEC on July 31, 2026

THOMSON REUTERS
·
Aug 03

Anavex Life Sciences Corp - Christopher Missling and Steffen Thomas to Leave Board After 2026 Annual Meeting

THOMSON REUTERS
·
Aug 03

Promising Penny Stocks To Consider In August 2026

Simply Wall St.
·
Aug 03

Anavex Urges Vote for Its Six Director Nominees as PVG Group Seeks Board Seats Ahead of Annual Meeting

Reuters
·
Aug 01

Werewolf Therapeutics Posts Q2 Profit on Jazz Asset Sale

Reuters
·
Jul 31

Tenax Therapeutics Q2 Net Loss Widens on Higher R&D Costs

Reuters
·
Jul 31

Anavex Life Sciences Corp Reports Results for the Quarter Ended March 31 - Earnings Summary

Reuters
·
Jul 31

Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) Estimate

Benzinga Earnings
·
Jul 30

Disc Medicine Posts Smaller-than-expected Q2 Net Loss

Reuters
·
Jul 30